Company Description

Trio Pharmaceuticals is a privately held cancer therapeutics company developing first-in-class dual action antibody drug conjugates, TRIObody Drug Conjugate (TDCﾙ), and dual action antibody drugs, TRIObodyﾙ, that stops both tumor growth and immunosuppression with and without payload delivery, respectively.